XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Sep. 30, 2021
Current assets    
Cash and cash equivalents $ 153,199,352 $ 152,107,745
Incentive and tax receivables 6,559,829 9,136,831
Prepaid expenses and other current assets 461,963 371,914
Total assets 160,221,144 161,616,490
Current Liabilities    
Accounts payable 3,126,892 4,739,781
Accrued liabilities (Note 4) 5,913,821 5,614,774
Deferred grant income 443,831 443,831
Total liabilities 9,484,544 10,798,386
Stockholders' equity    
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per share Issued and outstanding:77,942,568 common shares (September 30, 2021 - 75,918,465) 77,944 75,920
Additional paid-in capital 381,932,039 348,328,048
Accumulated deficit (231,273,383) (197,585,864)
Total stockholders' equity 150,736,600 150,818,104
Total liabilities and stockholders' equity $ 160,221,144 $ 161,616,490